Newsletters and Deep Dive digital magazine
Chronic heart failure (CHF) device specialist Impulse Dynamics has secured £30 million in financing.
A round-up of this week's top digital healthcare news. Marco Ricci reports.
Sandoz completed its long-heralded separation from Novartis on schedule this morning, with its shares trading at CHF 24 on the SIX Swiss Exchange.
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho